There are also free Cognitive Behavioural Therapy for Insomnia (CBT-I) programs people can do at home to make sleep a priority. Report cessation effects to the TGA Given GLP-1 agonist cessation is an emerging area, pharmacists should consider reporting any effects to the TGA, or encourage patients to self-report
Tirzepatide, a dual GLP-1/GIP receptor agonist has been approved for glycaemic control in type 2 diabetes as well as for obesity management leading in up to 22.5% WL in phase 3 obesity trials
A case of vesiculopustular eruption occurred 6 weeks after liraglutide use, with non-grouped vesicles and red borders on the thorax, abdomen, face, neck, arms, and lower extremities
Ayuda a retrasar la fatiga muscular durante el entrenamiento
New drugs for the treatment of diabetes: part II: incretin-based therapy and beyond
As researchers continue to explore the full potential of GLP-1 and related compounds, we can expect to see even more advanced treatments in the future